UNSPSC 51452100: Anthelmintic benzene derivatives

Anthelmintic drugs made from a toxic, volatile, flammable liquid hydrocarbon byproduct of coal distillation.

UNSPSC 51452100 Anthelmintic benzene derivatives is a Class code that in recent state and local practice encompasses procurement of pharmaceutical products, medical supplies, and health-related consumables rather than anthelmintic compounds specifically. State and local governments soliciting under this code are purchasing naloxone, first-aid and emergency medical supplies for fire and rescue operations, and generic multi-source pharmaceuticals and over-the-counter products for distribution through health systems and cooperative purchasing networks. Issuing bodies include county health departments, municipal fire departments, state health and human services commissions, and cooperative purchasing alliances serving multiple jurisdictions. The work being solicited reflects practical health-system and emergency-response supply chains rather than the narrower chemical-derivative scope the code's name suggests.

Recent activity spans Florida, Texas, and Minnesota through a mix of solicitation types. Seminole County, Florida released IFB 60459723LAS (due July 26, 2023, with a posting date of June 30, 2026) to procure 1,900 units of naloxone and 800 safe drug deactivation systems annually for quarterly delivery to the Seminole County Community Health Building in Sanford. The City of Tampa's Purchasing Department issued IFB 26P00145 (due March 13, 2026) for 169 line items of medical and first-aid supplies totaling an estimated $700,000 for the Tampa Fire Department Rescue Division, with award designated as a sheltered market opportunity for certified Small Local Business Enterprises. The Texas Health and Human Services Commission posted RFI HHS0017013 (due April 3, 2026) to gather vendor capabilities on direct-to-manufacturer prescription programs outside traditional pharmacy benefit manager arrangements. The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP) issued RFP S1070000015802 (due March 26, 2026) to establish multiple contracts for generic pharmaceuticals and OTC products distributed through authorized wholesalers to state and local facilities in Minnesota and Oregon. The code shows fragmented activity across health departments, municipal services, and cooperative purchasing vehicles with no dominant repeat buyer.